Comera Life Sciences Q3 EPS $(0.10) Up From $(0.20) YoY, Sales $136.31K Down From $234.92K YoY
Comera Life Sciences Q3 EPS $(0.10) Up From $(0.20) YoY, Sales $136.31K Down From $234.92K YoY
Comera Life Sciences第三季度每股收益爲0.10美元，高於同比0.20美元，銷售額從同比的234.92萬美元下降13.631萬美元
Comera Life Sciences (NASDAQ:CMRA) reported quarterly losses of $(0.10) per share. This is a 50 percent increase over losses of $(0.20) per share from the same period last year. The company reported $136.31 thousand in sales this quarter. This is a 41.98 percent decrease over sales of $234.92 thousand the same period last year.
Comera Life Sciences（納斯達克股票代碼：CMRA）公佈季度每股虧損0.10美元。這比去年同期每股虧損0.20美元（0.20美元）增加了50％。該公司報告本季度銷售額爲136,310美元。這比去年同期的234,920美元的銷售額下降了41.98％。